Sun City, AZNCT07282665Now EnrollingIRB Ready

Clostridioides Difficile Associated Disease Clinical Trial in Sun City, AZ

Access cutting-edge clostridioides difficile associated disease treatment through this clinical trial at a research site in Sun City. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this Sun City location

Preparing your pre-screening questions…

Expert Care in Sun City

Access clostridioides difficile associated disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related clostridioides difficile associated disease treatment provided free

Apply for This Sun City Location

Check if you qualify for this clostridioides difficile associated disease clinical trial in Sun City, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sun City

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sun City site if eligible
  4. 4Begin participation

About This Clostridioides Difficile Associated Disease Study in Sun City

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placebo (saline). A placebo does not contain any active ingredients. The vaccines will be given as a shot into the upper arm muscle. This study looks at the number of diarrhea (loose stools) events related to a C. difficile infection, so the length of the study can change. If these events happen quickly, the study may finish sooner; if they happen slowly, it could take longer. Sometimes, the study might stop early if the vaccine clearly works or clearly doesn't. Participants will stay in the study until enough events have occurred to answer the main question. On average, each person is expected to take part for up to about three and a half years. During this time, participants will have 3 planned clinical visits and 3 planned phone visits. After these visits, more scheduled clinic visits will happen every year until the end of study. Besides the scheduled study visits, if at any time during the study a participant has 3 or more loose stools in 24 hours, they will be asked to save the next one (the fourth or later) and contact the study site. The study site will check to see if it could be a C. difficile infection. This check may happen at the clinic or through a phone or video call.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

): • People with recent or future planned contact with healthcare systems or who have recently received antibiotics. Who Cannot Join the Study (

Exclusion Criteria

Anyone who has had CDI before.
Anyone who has had surgery to remove part of their small or large intestine.
Anyone who often has diarrhea (meaning three or more loose stools in a day, more than once a month).
Anyone who has already received a vaccine or special antibody treatment for C. difficile.
Anyone who has had a serious allergic reaction to a vaccine or to any part of the study vaccines.
Anyone who might not respond well to the vaccine because their immune system is weak (either from a disease or from treatment).
Anyone with cancer that has spread, kidney failure, or another serious health problem.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sun City?

Yes, this clinical trial (NCT07282665) has an active research site in Sun City, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Clostridioides Difficile Associated Disease Treatment Options in Sun City, AZ

If you're searching for clostridioides difficile associated disease treatment options in Sun City, AZ, this clinical trial (NCT07282665) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sun City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced clostridioides difficile associated disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all clostridioides difficile associated disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Sun City, AZ

See all ankylosing spondylitis clinical trials recruiting in Sun City — not just this study.

Browse Ankylosing Spondylitis Trials in Sun City

Ready to Join in Sun City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sun City, AZ